Freds inc (FRED)
CashFlow / Yearly
Feb'19Feb'18Jan'18Jan'17Jan'16Jan'15Jan'14Jan'13Jan'12Jan'11Jan'10
Cash flows from operating activities:
Net loss

-137,183

-144,539

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-28,904

26,015

29,629

33,428

29,587

23,615

Net loss

-

-

-139,267

-68,125

-8,945

-

-

-

-

-

-

Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation and amortization

31,273

35,301

42,580

44,014

43,100

41,029

41,047

39,541

34,190

29,236

26,387

Net gain on asset disposition

3,624

275

275

846

2,887

3,601

3,972

-

-

-

-

Provision for store closures

286

7,690

-

-

-

-

-

-

-

-

-

Asset impairments

33,243

2,489

23,853

25,362

1,376

16,125

1,700

-

-

-

-

Net gain on asset disposition

-

-

-

-

-

-

-

471

2,761

-741

-356

Provision (recovery) for store closures and asset impairment

-

-

-

-

-

-

-

-67

-

-

-

Provision (benefit) for store closures and asset impairment

-

-

-

-

-

-

-

-

112

340

-

Stock-based compensation

3,279

4,619

4,619

8,775

2,247

2,433

1,791

2,055

2,075

1,886

1,595

(Recovery) for uncollectible receivables

-25

-241

-241

-919

166

1,383

103

627

447

455

-

Provision for uncollectible receivables

-

-

-

-

-

-

-

-

-

-

121

LIFO reserve increase

-

1,446

1,278

5,091

7,545

4,734

4,526

3,937

2,792

2,406

2,411

Deferred income tax benefit

100

-2,083

-2,083

-7,772

-831

-13,289

-5,165

-583

6,462

1,898

5,932

Income tax benefit (charge) upon exercise of stock options

-

-

-

-

-

-1

-23

30

27

-

-

Amortization of debt issuance costs

594

273

273

105

154

34

-

-

-

-

-

Benefit for postretirement medical

1

1

1

55

45

84

82

91

85

97

74

(Increase) decrease in operating assets:
Income tax benefit upon exercise of stock options

-

-

-

-

-

-

-

-

-

10

-

Income tax benefit upon exercise of stock options

-

-

-

-

-

-

-

-

-

-

43

Trade and non-trade receivables

-14,618

-3,650

-3,650

-987

3,570

-2,153

5,213

8,223

8,313

6,199

1,812

Insurance receivables

-

-276

-276

69

301

441

-298

273

-205

-1,390

780

Inventories

-17,514

-28,723

-28,949

11,639

30,351

-28,404

14,953

25,254

21,402

22,106

-5,101

Other assets

592

-6,983

-6,983

-595

-2,945

-420

111

615

-607

1,330

-1,369

Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses

-41,732

5,083

5,083

-27,964

32,938

16,689

12,835

8,068

25,464

-641

11,593

Income taxes receivable

1,255

-5

-

-

-

-

-

-

-

-

-

Income taxes payable

-

-

-5

7,175

8,432

-13,683

-

2,627

-1,719

3,813

-7,925

Income taxes receivable

-

-

-

-

-

-

921

-

-

-

-

Other noncurrent liabilities

-10,527

5,907

5,907

-2,842

-2,261

10,302

986

-6,187

1,801

668

-3,441

Net cash used in operating activities of continuing operations

-91,523

-44,703

-

-

-

63,703

58,861

44,750

-

-

-

Net cash provided by (used in) operating activities

-

-

-18,421

-28,127

49,712

-

-

-

73,330

42,057

64,249

Cash flows from investing activities of continuing operations:
Cash flows from investing activities of continuing operations:
Capital expenditures

9,005

15,753

15,753

23,940

22,800

23,308

25,918

20,203

16,770

11,451

10,663

Capital expenditures

-

-

-

-

-

-

-

27,391

45,681

27,013

22,692

Proceeds from asset dispositions

2,203

2,206

2,206

2,619

3,747

4,861

6,267

1,593

3,354

168

125

Net proceeds from discontinued operations

215,469

-

-

-

-

-

-

-

-

-

-

Insurance recoveries for replacement assets

-

119

119

416

0

0

176

0

0

98

-

Asset acquisitions, net (primarily intangibles)

-

1,718

1,718

12,700

16,596

37,605

25,066

-

-

-

-

Net cash provided by (used in) investing activities of continuing operations

-

-

-15,146

-33,605

-26,527

-

-

-

-59,097

-38,198

-33,230

Acquisition of Reeves-Sain Drug Store, Inc., net of cash

-

-

0

0

-9,122

0

0

-

-

-

-

Net cash provided by (used in) investing activities of continuing operations

208,667

-15,146

-

-

-

-56,052

-44,541

-46,001

-

-

-

Cash flows from financing activities of continuing operations:
Payments of indebtedness and capital lease obligations

64

59

59

621

554

2,472

1,308

-

-

-

-

Payments of indebtedness and capital lease obligations

-

-

-

-

-

-

-

693

514

727

212

Proceeds from revolving line of credit

741,210

910,181

910,181

990,965

937,164

455,079

235,313

78,444

0

0

-

Payments on revolving line of credit

835,402

871,081

871,081

914,962

902,681

451,236

242,279

71,547

0

0

-

Debt issuance costs

416

597

597

5,831

525

0

11

-

-

-

-

Proceeds (payments) from exercise of stock options and employee stock purchase plan

149

39

-

-

-

-

-

-

-

-

-

Transfer (to) from discontinued operations

17,695

-21,464

-

-

-

-

-

-

-

-

-

Excess tax charges from stock-based compensation

-

-

-

-

-

1

23

-

-

-10

-43

Excess tax charges from stock-based compensation

-

-

-

-

-

-

-

-

27

-

-

Excess tax benefit (charges) from stock-based compensation

-

-

-

-

-

-

-

-30

-

-

-

Proceeds (payments) from exercise of stock options and employee stock purchase plan

-

-

-39

553

2,462

-462

1,368

1,109

451

595

408

(Distributions to)/contribution from subsidiary

-

-

7,727

510

-50,645

-

-

-

-

-

-

Repurchase of shares

5,848

4,975

4,975

0

0

-

-

-

-

-

-

Repurchase of shares

-

-

-

-

-

-

0

9,176

28,482

2,989

7,152

Cash dividends paid

-

6,847

6,847

8,969

8,929

8,846

8,830

15,857

7,713

6,288

4,406

Net cash (used in ) provided by financing activities of continuing operations

-118,364

48,047

-

-

-

-7,936

-15,724

-17,750

-

-

-

Decrease in cash and cash equivalents

-1,220

-11,802

-

-

-

-

-

-

-

-

-

Cash flow from discontinued operations
Cash flows from operating activities of discontinued operations, net

-17,695

26,282

8,547

1,022

1,388

-

-

-

-

-

-

Cash flows from investing activities of discontinued operations, net

0

0

-820

-512

-52,033

-

-

-

-

-

-

Cash flows from financing activities of discontinued operations, net

17,695

-13,737

-7,727

-510

50,645

-

-

-

-

-

-

Net cash provided by financing activities

-

-

34,310

61,645

-23,708

-

-

-

-36,285

-9,419

-11,405

Net increase (decrease) in cash and cash equivalents

-1,220

743

743

-87

-523

-285

-1,404

-19,001

-22,052

-5,560

19,614

Net decrease in cash and cash equivalents

-

-

0

0

0

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-1,220

743

743

-87

-523

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-1,220

743

743

-87

-523

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

0

0

0

-

-

-

-

-

-

Supplemental disclosures of cash flow information:
Interest paid

7,747

6,297

6,297

2,318

1,431

-

-

-

-

-

-

Interest paid

-

-

-

-

-

504

487

549

397

190

293

Income taxes refunded

-1,648

-1,721

-1,721

-9,906

-12,911

8,045

19,831

-

-

-

-

Income taxes paid

-

-

-

-

-

-

-

15,447

13,126

7,145

22,999

Acquisition related note payable, see Note 11 - Business Combinations

-

-

0

0

13,000

0

0

-

-

-

-

Assets acquired through term loan

-

-

-

-

-

-

-

-

3,497

0

-

Restricted stock issued for the aquistion of intangible assets

-

-

-

-

-

-

-

-

135

200

-